---
$id: https://graph.org.ai/products/commodity/51171948
$type: Product
source: UNSPSC
code: "51171948"
title: "Lozilurea"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lozilurea

**UNSPSC Code**: 51171948
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C10H13ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 677AYV0R9N, chemically known as urea, n-(m-chlorobenzyl)-n-ethyl- but generally known as lozilurea, which bears US NIH Compound Identifier 68907. European Medicines Agency schedules Lozilurea in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08611MIG. The term LOZILUREA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). LOZILUREA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lozilurea under HS 29242190 and SITC 51473. As of Q4 2014, LOZILUREA remains the US FDA Preferred Term for this commodity. Lozilurea bears US NLM identifiers UMLS ID C0620245 and NCI Concept Code C66039. SMILES: CCNC(=O)NCC1=CC(=CC=C1)CL.

